UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
European urology, ISSN 0302-2838, 11/2017, Volume 72, Issue 5, pp. 757 - 769
Desmopressin | LUTS | IPSS | Nocturia | Guidelines | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Severity of Illness Index | Nocturia - drug therapy | Humans | Risk Factors | Lower Urinary Tract Symptoms - physiopathology | Male | Treatment Outcome | Lower Urinary Tract Symptoms - epidemiology | Nocturia - physiopathology | Nocturia - epidemiology | Recovery of Function | Urological Agents - adverse effects | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - diagnosis | Quality of Life | Nocturia - diagnosis | Urological Agents - therapeutic use | Robotic surgery | Medicine, Experimental | Transplantation of organs, tissues, etc | Medical colleges | Medical research | Public health | Index Medicus
Journal Article
BJU international, ISSN 1464-4096, 04/2015, Volume 115, Issue 4, pp. 508 - 519
epidemiology | economics | BPH | LUTS | quality of life | burden of illness | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Lower Urinary Tract Symptoms - psychology | Prostatic Hyperplasia - psychology | Humans | Middle Aged | Cost of Illness | Lower Urinary Tract Symptoms - physiopathology | Male | Lower Urinary Tract Symptoms - epidemiology | Prostatic Hyperplasia - epidemiology | Young Adult | Prostatic Hyperplasia - economics | Lower Urinary Tract Symptoms - economics | Aged, 80 and over | Quality of Life | Adult | Aged | Prostatic Hyperplasia - physiopathology | United Kingdom - epidemiology | Databases, Factual | Prostate | Hypertrophy | Aging | Mens health | Health services | Urogenital system | Quality of life | Index Medicus
Journal Article
Urology (Ridgewood, N.J.), ISSN 0090-4295, 08/2017, Volume 106, pp. 160 - 166
Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prognosis | Follow-Up Studies | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Lower Urinary Tract Symptoms - etiology | Humans | Lower Urinary Tract Symptoms - physiopathology | Male | Prostatic Hyperplasia - drug therapy | Prostatic Hyperplasia - complications | Randomized Controlled Trials as Topic | Urological Agents - therapeutic use | Biological products | Prostate | Analysis | Hypertrophy | Index Medicus
Journal Article
The Journal of urology, ISSN 0022-5347, 2013, Volume 190, Issue 4, pp. 1320 - 1327
Urology | urinary bladder neck obstruction | urodynamics | mirabegron | lower urinary tract symptoms | urinary bladder | bladder neck obstruction | urinary bladder urinary | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Double-Blind Method | Urinary Bladder Neck Obstruction - physiopathology | Humans | Middle Aged | Lower Urinary Tract Symptoms - physiopathology | Male | Thiazoles - therapeutic use | Adrenergic beta-3 Receptor Agonists - adverse effects | Thiazoles - adverse effects | Urodynamics | Adrenergic beta-3 Receptor Agonists - therapeutic use | Lower Urinary Tract Symptoms - drug therapy | Acetanilides - therapeutic use | Acetanilides - adverse effects | Urinary Bladder Neck Obstruction - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Neurourology and urodynamics, ISSN 0733-2467, 02/2019, Volume 38, Issue 2, pp. 433 - 477
lower urinary tract dysfunction | male urinary tract imaging | GOOD URODYNAMIC PRACTICES | JOINT REPORT | ULTRASOUND MEASUREMENT | NOCTURNAL POLYURIA | DETRUSOR WALL THICKNESS | male urodynamics | STANDARDIZATION SUB-COMMITTEE | OVERACTIVE BLADDER | terminology | BLADDER OUTLET OBSTRUCTION | INTRAVESICAL PROSTATIC PROTRUSION | QUALITY-OF-LIFE | lower urinary tract symptoms | male | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Societies, Medical | Pelvic Floor - physiopathology | Humans | Terminology as Topic | Urinary Bladder - physiopathology | Adult | Male | Pelvic Floor Disorders - diagnosis | Pelvic Floor Disorders - physiopathology | Consensus | Urology | Associations, institutions, etc | Terms and phrases | Societies | Magnetic resonance imaging | Computed tomography | Decision making | Jargon | Urinary tract | Ultrasound | Urogenital system | Index Medicus
Journal Article
European urology, ISSN 0302-2838, 2013, Volume 64, Issue 1, pp. 118 - 140
Urology | α-Adrenoreceptor antagonist | Desmopressin | Botulinum toxin injections | Transurethral resection of the prostate | Ethanol injections | 5α-Reductase inhibitor | Transurethral needle ablation | Prostate stent | Transurethral incision of the prostate | Muscarinic receptor antagonist | Open prostatectomy | Laser prostatectomy | Benign prostatic hyperplasia | Transurethral microwave therapy | Bipolar transurethral resection of the prostate | Lower urinary tract symptoms | Phosphodiesterase inhibitors | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Severity of Illness Index | Phosphodiesterase Inhibitors - therapeutic use | Risk Reduction Behavior | Humans | Prostatic Hyperplasia - therapy | Lower Urinary Tract Symptoms - physiopathology | Male | Transurethral Resection of Prostate - adverse effects | Treatment Outcome | 5-alpha Reductase Inhibitors - therapeutic use | Muscarinic Antagonists - therapeutic use | Lower Urinary Tract Symptoms - therapy | Transurethral Resection of Prostate - standards | Urology - standards | Urological Agents - adverse effects | Prostatic Hyperplasia - diagnosis | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | Urinary Catheterization - standards | Lower Urinary Tract Symptoms - diagnosis | Prostatic Hyperplasia - physiopathology | Stents - standards | Watchful Waiting - standards | Urological Agents - therapeutic use | Practice guidelines (Medicine) | Medical colleges | Bipolar disorder | Desmopressin acetate | Ablation (Surgery) | Index Medicus
Journal Article
BJU international, ISSN 1464-4096, 02/2008, Volume 101, Issue 3, pp. 319 - 324
ischaemia | perfusion of bladder and prostate | lower urinary tract symptoms | tamsulosin | α‐blocker | Ischaemia | Perfusion of bladder and prostate | Tamsulosin | α-blocker | Lower urinary tract symptoms | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Prostatism - physiopathology | Humans | Middle Aged | Adrenergic alpha-Antagonists - therapeutic use | Male | Case-Control Studies | Prostatic Hyperplasia - complications | Urodynamics - physiology | Prostatism - drug therapy | Swine | Ultrasonography | Urinary Bladder - diagnostic imaging | Adult | Prostate - blood supply | Prostate - physiopathology | Ischemia - diagnostic imaging | Prostatism - diagnostic imaging | Treatment Outcome | Ischemia - physiopathology | Animals | Ischemia - drug therapy | Sulfonamides - therapeutic use | Prostate - diagnostic imaging | Urinary Bladder - physiopathology | Urinary Bladder - blood supply | Aged | Chronic Disease | Index Medicus
Journal Article